| Literature DB >> 26069293 |
Jasmijn D E de Rooij1, Eva Beuling1, Marry M van den Heuvel-Eibrink2, Askar Obulkasim1, André Baruchel3, Jan Trka4, Dirk Reinhardt5, Edwin Sonneveld6, Brenda E S Gibson7, Rob Pieters8, Martin Zimmermann4, C Michel Zwaan1, Maarten Fornerod9.
Abstract
IKAROS family zinc finger 1/IKZF1 is a transcription factor important in lymphoid differentiation, and a known tumor suppressor in acute lymphoid leukemia. Recent studies suggest that IKZF1 is also involved in myeloid differentiation. To investigate whether IKZF1 deletions also play a role in pediatric acute myeloid leukemia, we screened a panel of pediatric acute myeloid leukemia samples for deletions of the IKZF1 locus using multiplex ligation-dependent probe amplification and for mutations using direct sequencing. Three patients were identified with a single amino acid variant without change of IKZF1 length. No frame-shift mutations were found. Out of 11 patients with an IKZF1 deletion, 8 samples revealed a complete loss of chromosome 7, and 3 cases a focal deletion of 0.1-0.9Mb. These deletions included the complete IKZF1 gene (n=2) or exons 1-4 (n=1), all leading to a loss of IKZF1 function. Interestingly, differentially expressed genes in monosomy 7 cases (n=8) when compared to non-deleted samples (n=247) significantly correlated with gene expression changes in focal IKZF1-deleted cases (n=3). Genes with increased expression included genes involved in myeloid cell self-renewal and cell cycle, and a significant portion of GATA target genes and GATA factors. Together, these results suggest that loss of IKZF1 is recurrent in pediatric acute myeloid leukemia and might be a determinant of oncogenesis in acute myeloid leukemia with monosomy 7. Copyright© Ferrata Storti Foundation.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26069293 PMCID: PMC4800704 DOI: 10.3324/haematol.2015.124321
Source DB: PubMed Journal: Haematologica ISSN: 0390-6078 Impact factor: 9.941